top of page

Lunch&Learn: The Swiss Drug Pricing Model (SDPM)

The Swiss Drug Pricing Model (SDPM), a tool for evidence-based, efficient and transparent pricing of new therapies

Switzerland is exploring new ways to ensure fair pricing for innovative therapies


Speaker: Nikalus Meier


On 1 October 2025, VBHC Suisse had a free lunchtime webinar on the Swiss Drug Pricing Model – a transparent, evidence-based approach to calculating economically justified prices for new treatments.


Niklaus Meier, co-developer of the model, presented key insights.


The session was moderated by Eva Blozik.


bottom of page